自动胰岛素输注期间向免校准传感器与远程监测过渡的用户体验：一项定性研究 Table_1

数据集获取（Figshare）

• 源站标题：Table_1_User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative study.docx
• DOI：10.3389/fendo.2023.1214975.s001
• 发布日期：2023-08-24
• 文件数：1 个
• 文件总体积：16.81 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_User_experiences_during_the_transition_to_calibration-free_sensors_with_remote_monitoring_while_using_automated_insulin_delivery_-_a_qualitative_study_docx/24023742

命令行下载

curl -L -o "Table_1_User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitati.docx" "https://ndownloader.figshare.com/files/42125106"

文件清单

• Table_1_User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitati.docx（16.81 KB）

文件总体积 16.81 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

IntroductionTo evaluate the experiences of patients with type 1 diabetes following transition from a calibration-requiring to a calibration-free sensor and remote monitoring in the context of using automated insulin delivery (AID).
Research design and methodsFifteen participants aged 7–65 years with type 1 diabetes participating in a longitudinal study used a Medtronic® advanced hybrid closed loop (AHCL) device with initially calibration-requiring then calibration-free sensors. Qualitative interviews were conducted ≥20 weeks following use of the calibration-requiring and ≥4 weeks after use of the calibration-free sensors/remote monitoring. Thematic analysis was used to identify key themes and subthemes.
ResultsAt baseline, mean diabetes duration was 14.5 years ( ± 10.9), mean Hba1c 54.8 mmol/mol ( ± 10.2) (7.2 ± 0.9%) and Time in range 75.4% ( ± 11.6). Participants reported a progressive improvement in digital and lifestyle integration, and device trust following transition to calibration-free sensors with remote monitoring potential. They also reported a reduced need for capillary glucose, increased device satisfaction and trust, and reduced burden of diabetes care. Negative aspects reported included periodic early sensor loss, and for some, impaired integration with mobile devices.
ConclusionTransitioning to calibration-free sensors with remote monitoring while using AHCL was associated with better user experience, including perceptions of improved quality of life and a reduced burden of diabetes care. Appropriate expectation setting, training, and ongoing support allow for the optimal user experience while using AHCL.
Clinical trial registrationhttps://www.anzctr.org.au, identifier ACTRN12621000360819

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fendo.2023.1214975.s001（source: https://frontiersin.figshare.com/articles/dataset/Table_1_User_experiences_during_the_transition_to_calibration-free_sensors_with_remote_monitoring_while_using_automated_insulin_delivery_-_a_qualitative_study_docx/24023742）。